Between Jan. 1, 2015 and April 25, 2015, the Ministry of Public Health of Niger notified the World Health Organization (WHO) of 1,543 suspected cases of meningococcal disease, including 147 deaths. Suspected cases have been reported in seven of Niger’s eight regions. Meningococcal meningitis outbreaks have been confirmed in several areas of Dosso and Niamey regions.
In Dosso region, 282 cases, including 27 deaths have been reported, primarily from Dogon-Doutchi and Gaya districts where several areas have exceeded the epidemic threshold. In Niamey, 944 suspected cases, including 88 deaths, have so far been reported. Three of Niamey’s five districts (Niamey I, II and III, with a total population of over 660 000) have exceeded the epidemic threshold.
Laboratory tests have confirmed the predominance of Neisseria meningitidis serogroup C in the affected areas, with Neisseria meningitidis serogroup W also being identified in several samples.
A national epidemic committee has been activated to manage the outbreak. An international investigation team composed of WHO and CDC has been deployed to support the Ministry of Public Health’s investigation of the outbreak and reinforce the surveillance capacity in the country.
WHO and partners are providing support to the government of Niger for the implementation of mass vaccination campaigns and other emergency control measures. The International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis Control has approved three vaccination requests, one from MSF and two from the MoH with support from WHO and UNICEF, releasing in total 460,000 doses of ACW vaccine, as well as 18,500 antibiotic vials to respond to the outbreak. Case management and social mobilisation activities are also ongoing.
Source: WHO
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.